Global Next Generation Implants (NGI) Market Analysis and Forecast 2017-2023

[junkie-button url=”https://infomeddnews.com” style=”grey” size=”medium” type=”round” target=”_blank”] HOME [/junkie-button]

[junkie-alert style=”white”] The global next generation implants market is estimated to grow over $3.9 billion by 2023 [/junkie-alert]

On the other hand, the conventional implants market is estimated to grow over $103 billion in 2023. On the basis of application, the market is segmented into orthopedic, cardiovascular, dental, ocular and other implants. As per the raw material, the metals and its alloys are dominating the conventional implants market with an estimated value of $25 billion in 2016.

North America was estimated to be the leader in 2016 in conventional implants with a market value of $30 billion in 2016 mainly due to rising geriatric population and increased prevalence of diseases. The fastest growing market is expected to Asia Pacific with a CAGR of 8.7% from 2017 to 2023. The market is strongly driven by the technological advancement & evolution of implants. The use of better materials, automated surgeries, biological materials, personalised implants, better care, and decreased risk of infection are contributing to increased patients’ and physicians’ interest in the market.

The report provides in-depth SWOT analysis of different key players of the market, supported by extensive financial summary of each.

Key Topics Covered:

Executive Summary

1 Report Scope

2 Market Overview

3 Market Dynamics

4 Industry Insights

5 Competitive Landscape

6 Global Next Generation Implants Market, by Application

7 Global Next Generation Implants Market, by Material

8 Global Next Generation Implants Market, by Geography

9 Company Profiles

  • Abbott Laboratories
  • Arthrex
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Danaher Corporation
  • Dentsply Sirna Inc.
  • Edwards Lifesciences Corporation
  • Endo International Plc
  • Globus Medical Inc.
  • Integer Holdings Corporation
  • Integra Lifesciences Corporation
  • Institut Straumann AG
  • Johnson & Johnson
  • Lifenet Health, Inc.
  • Livanova Plc
  • Medtronic Public Limited Company
  • Novartis International Ag
  • Nuvasive, Inc.
  • Orthofix Holdings, Inc.
  • Smith & Nephew Plc
  • Stryker Corporation
  • Symetis SA
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • Wright Medical Group N.V
  • Zimmer Biomet Holdings Inc

Additional information can be found here.